Gut Microbiota in IBD: The Beneficial and Adverse Effects of Diet and Medication
Nutrients · 2025
DOI: 10.3390/nu18010009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Aidan Eric Juhl und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Florida Gulf Coast University, Fort Myers, FL 33965, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Diet, Inflammatory Bowel Diseases, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation fonden.
Abstract (Originalsprache)
Background
Inflammatory bowel disease (IBD) is a global disease with a considerable increase in prevalence and the impact on the health and well-being of patients suffering from this condition is vast. Diet has been suspected of being a contributor to IBD severity as well as intake of antibiotics.
Methods
A literary search was conducted on the most recent studies on the subject of IBD, diet, and medical treatment to identify high-quality research findings within this area of research. Research published within the last decade was prioritized. Studies in English language were included in the search, and the knowledge gained was synthesized in the review.
Results
Dietary patterns, specifically intake of Westernized diets, were associated with increased inflammation and increased disease severity in patients suffering from IBD, specifically patients suffering from Crohn’s disease (CD). A co-administration of pre- and probiotics was found to contribute to disease remission in ulcerative colitis patients, however, to a lesser extent in patients with CD. A bidirectional effect on the intestinal microbiome was seen as a result of intake of the medicines used for the treatment of IBD patients, which affects both bioavailability of the drug and efficacy of the treatment. The baseline composition of the intestinal microbiome in IBD patients dictates their response to the different treatments.
Conclusions
Diet and medical treatment both have a large impact on the architecture of the intestinal Microbiome in IBD patients and are, as such, both essential to understand to enable individualized and optimized treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Florida Gulf Coast University, Fort Myers, FL 33965, USA.
- Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, 5000 Odense, Denmark.
- Center for General Practice, Department of Public Health, University of Copenhagen, 1353 Copenhagen, Denmark.
- Department of Gastroenterology, Copenhagen University Hospital Hvidovre, 2650 Hvidovre, Denmark.
- Department of Infectious Diseases, Copenhagen University Hospital Hvidovre, 2650 Hvidovre, Denmark.
- Department of Research and Development, 1Health Gut Inn Balance, 2680 Solroed Strand, Denmark.
ORCID-Profile: Betina Hebbelstrup Jensen
Förderung
- Innovation fonden
Zitieren
APA
Juhl, A. E., Westfall, M., Hebbelstrup Jensen, B., & Mirsepasi-Lauridsen, H. C. (2025). Gut Microbiota in IBD: The Beneficial and Adverse Effects of Diet and Medication. Nutrients. https://doi.org/10.3390/nu18010009
Vancouver
Juhl AE, Westfall M, Hebbelstrup Jensen B, Mirsepasi-Lauridsen HC. Gut Microbiota in IBD: The Beneficial and Adverse Effects of Diet and Medication. Nutrients. 2025. doi:10.3390/nu18010009
BibTeX
@article{Juhl2025,
author = {Juhl, Aidan Eric and Westfall, Morten and Hebbelstrup Jensen, Betina and Mirsepasi-Lauridsen, Hengameh Chloé},
title = {Gut Microbiota in IBD: The Beneficial and Adverse Effects of Diet and Medication},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu18010009}
}
EUVIMED